Works matching IS 00070920 AND DT 2006 AND VI 95 AND IP 4


Results: 20
    1
    2

    Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

    Published in:
    British Journal of Cancer, 2006, v. 95, n. 4, p. 463, doi. 10.1038/sj.bjc.6603271
    By:
    • Atzpodien, J.;
    • Kirchner, H.;
    • Rebmann, U.;
    • Soder, M.;
    • Gertenbach, U.;
    • Siebels, M.;
    • Roigas, J.;
    • Raschke, R.;
    • Salm, S.;
    • Schwindl, B.;
    • Müller, S. C.;
    • Hauser, S.;
    • Leiber, C.;
    • Huland, E.;
    • Heinzer, H.;
    • Siemer, S.;
    • Metzner, B.;
    • Heynemann, H.;
    • Fornara, P.;
    • Reitz, M.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20